Finance

Lists
Why is 300204 up 3.64%?
Dive Deeper
300204:SHE
Staidson (Beijing) BioPharmcutcls Co Ltd
CNÂ¥17.35
+3.64%
(+0.61) 1D
Nov 4, 3:04:19 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300204...
Open
CNÂ¥16.80
High
CNÂ¥17.39
Low
CNÂ¥16.52
Mkt. cap
9.06B
Avg. vol.
12.39M
Volume
13.37M
52-wk high
CNÂ¥41.17
52-wk low
CNÂ¥16.30
EPS
-CNÂ¥0.21
Shares outstanding
541.34M
No. of employees
491
Open
CNÂ¥16.80
High
CNÂ¥17.39
Low
CNÂ¥16.52
Mkt. cap
9.06B
Avg. vol.
12.39M
Volume
13.37M
52-wk high
CNÂ¥41.17
52-wk low
CNÂ¥16.30
EPS
-CNÂ¥0.21
Shares outstanding
541.34M
No. of employees
491
News stories
From web sources and news partners
About Staidson (Beijing) BioPharmcutcls Co Ltd
CEO-
Employees491
FoundedAug 16, 2002
Headquarters-
SectorBiotechnology
Industry-
Websitestaidson.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
39.69M
46.90M
46.00M
54.29M
Cost of goods sold
11.32M
10.23M
14.61M
15.30M
Cost of revenue
11.32M
10.23M
14.61M
15.30M
Research and development expenses
26.83M
12.21M
17.66M
10.42M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
47.90M
29.37M
39.45M
40.80M
Operating expense
74.75M
42.24M
58.51M
50.42M
Total operating expenses
86.07M
52.47M
73.11M
65.72M
Operating income
-46.38M
-5.57M
-27.11M
-11.43M
Other non operating income
-92.37K
-220.74K
210.84K
-11.18M
EBT including unusual items
-50.52M
-9.28M
-29.58M
-16.66M
EBT excluding unusual items
-49.70M
-8.89M
-30.77M
-15.41M
Income tax expense
-296.49K
-1.49K
1.56K
-281.00
Effective tax rate
0.59%
0.02%
-0.01%
-
Other operating expenses
176.72K
603.57K
1.50M
-840.66K
Net income
-47.07M
-8.43M
-28.34M
-15.70M
Net profit margin
-118.59%
-17.98%
-61.60%
-28.92%
Earnings per share
-
-
-
-
Interest and investment income
489.14K
365.59K
551.26K
7.47M
Interest expense
-3.45M
-3.66M
-3.82M
-679.30K
Net interest expenses
-2.96M
-3.29M
-3.26M
6.79M
Depreciation and amortization charges
-
-
-
-
EBITDA
-40.49M
317.58K
-20.45M
-5.54M
Gain or loss from assets sale
-875.15K
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps